Atara Biotherapeutics
ATRA
ATRA
140 hedge funds and large institutions have $1.06B invested in Atara Biotherapeutics in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 37 reducing their positions, and 14 closing their positions.
Holders
140
Holders Change
+18
Holders Change %
+14.75%
% of All Funds
2.83%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
33
Increased
52
Reduced
37
Closed
14
Calls
$1.76M
Puts
$778K
Net Calls
+$983K
Net Calls Change
+$227K
Top Buyers
| 1 |
WA
1
Wasatch Advisors
Salt Lake City,
Utah
|
$35.4M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$73M |
| 3 |
3
BlackRock
New York
|
$76.4M |
| 4 |
4
Morgan Stanley
New York
|
$17M |
| 5 |
IC
5
Ikarian Capital
Dallas,
Texas
|
$5.53M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ACM
151
AlphaCrest Capital Management
New York
| – | – | -13,000 | Closed |
|
|
PHK
152
Point72 Hong Kong
Hong Kong
| – | – | -5,336 | Closed |
|
|
AWM
153
AllSquare Wealth Management
Albany,
New York
| – | – | -400 | Closed |
|
|
SF
154
Synovus Financial
Columbus,
Georgia
| – | – | -159 | Closed |
|
155
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
156
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
HT
157
HAP Trading
New York
| – | – | – | – |
|